SavedAdd your journal

Journals / Ankara Üniversitesi Eczacılık Fakültesi Dergisi / 2026 / Cilt: 46 Sayı: 2

PREPARATION AND IN VITRO CHARACTERIZATION OF VANCOMYCIN LOADED PLGA NANOPARTICLES FOR THE TREATMENT OF ENTEROCOCCUS FAECALIS INFECTIONS

ENTEROKOK ENFEKSİYONLARINDA KULLANILMAK ÜZERE VANCOMİSİN İÇEREN PLGA NANOPARTİKÜLLERİN HAZIRLANMASI VE KARAKTERİZASYONU

Gizem Rüya Topal(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, GÜLHANE ECZACILIK FAKÜLTESİ, ECZACILIK TEKNOLOJİSİ BÖLÜMÜ, FARMASÖTİK BİYOTEKNOLOJİ ANABİLİM DALI)0000-0002-7715-6383
Merve Eylül Kıymacı(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, GÜLHANE ECZACILIK FAKÜLTESİ, TEMEL ECZACILIK BİLİMLERİ BÖLÜMÜ, FARMASÖTİK MİKROBİYOLOJİ ANABİLİM DALI)0000-0001-5343-1064
Yalçın Özkan(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, GÜLHANE ECZACILIK FAKÜLTESİ, ECZACILIK TEKNOLOJİSİ BÖLÜMÜ, FARMASÖTİK TEKNOLOJİ ANABİLİM DALI)0000-0001-5163-6867
Pages
350–363
Publication Date
2022-05-29
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objective: In this study, it was aimed to prepare Vancomycin loaded poly(lactic acid-co-glycolic acid) (PLGA) nanoparticles that can be used parenterally in enterococcal infections.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, it was aimed to prepare Vancomycin loaded poly(lactic acid-co-glycolic acid) (PLGA) nanoparticles that can be used parenterally in enterococcal infections.
📊
Key Findings & Data:Objective: In this study, it was aimed to prepare Vancomycin loaded poly(lactic acid-co-glycolic acid) (PLGA) nanoparticles that can be used parenterally in enterococcal infections.
💡
Conclusion & Impact:Objective: In this study, it was aimed to prepare Vancomycin loaded poly(lactic acid-co-glycolic acid) (PLGA) nanoparticles that can be used parenterally in enterococcal infections.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Antibakteriyel aktivite · Enterococcus faecalis · Nanopartikül

Abstract

Objective: In this study, it was aimed to prepare Vancomycin loaded poly(lactic acid-co-glycolic acid) (PLGA) nanoparticles that can be used parenterally in enterococcal infections.

Özet

Amaç: Bu çalışmada enterokok enfeksiyonlarında parenteral olarak kullanılabilecek Vankomisin yüklü poli(laktik asit-ko-glikolik asit) (PLGA) nanopartikülleri hazırlanması amaçlanmıştır.

🔖

Cite This Article

Topal, G. R., Kıymacı, M. E., Özkan, Y. (2022). PREPARATION AND IN VITRO CHARACTERIZATION OF VANCOMYCIN LOADED PLGA NANOPARTICLES FOR THE TREATMENT OF ENTEROCOCCUS FAECALIS INFECTIONS. Ankara Üniversitesi Eczacılık Fakültesi Dergisi, Cilt: 46 Sayı: 2, 350–363. https://doi.org/10.33483/jfpau.1073081

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (29)

  1. Yıldırım, M. (2022). Enterokoklar ve Enterokoklarla Gelisen Infeksiyonlar. 9.
  2. Said MS, Tirthani E, Lesho E. Enterococcus Infections. (2021). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021
  3. Tünger, Ö. (2012). Vankomisine dirençli enterokok infeksiyonlarının tedavisinde eski ve yeni tedavi seçenekleri. ANKEM Dergisi, 26(4), 215-227.
  4. Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001). Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release, 70(1), 1-20.
  5. Anderson, J. M., & Shive, M. S. (1997). Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Delivery Reviews, 28(1), 5-24.
  6. Valizadeh, H., Mohammadi, G., R.Ehyaei, Milani, M., Azhdarzadeh, M., Zakeri-Milani, P., & Lotfipour, F. (2012). Antibacterial activity of clarithromycin loaded PLGA nanoparticles. Pharmazie, 67, 63-68.
  7. Verderio, P., Bonetti, P., Colombo, M., Pandolfi, L., & Prosperi, D. (2013). Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells. Biomacromolecules, 14(3), 672-682.
  8. Lotfipour, F., Abdollahi, S., Jelvehgari, M., Valizadeh, H., Hassan, M., & Milani, M. (2014). Study of antimicrobial effects of vancomycin loaded PLGA nanoparticles against enterococcus clinical isolates. Drug Res (Stuttg), 64(7), 348-352.
  9. Anwer, M. K., Al-Mansoor, M. A., Jamil, S., Al-Shdefat, R., Ansari, M. N., & Shakeel, F. (2016). Development and evaluation of PLGA polymer based nanoparticles of quercetin. Int J Biol Macromol, 92, 213-219.
  10. Esim, O., Bakirhan, N. K., Sarper, M., Savaser, A., Ozkan, S. A., & Ozkan, Y. (2020). Influence of emulsifiers on the formation and in vitro anticancer activity of epirubicin loaded PLGA nanoparticles. Journal of Drug Delivery Science and Technology, 60, 102027.
  11. Zakeri-Milani, P., Loveymi, B. D., Jelvehgari, M., & Valizadeh, H. (2013). The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system. Colloids Surf B Biointerfaces, 103, 174-181.
  12. Topal, G. R., Devrim, B., Eryilmaz, M., & Bozkir, A. (2018). Design of ciprofloxacin-loaded nano-and microcomposite particles for dry powder inhaler formulations: preparation, in vitro characterisation, and antimicrobial efficacy. J Microencapsul, 35(6), 533-547.
  13. Simon, A., Moreira, M. L. A., Costa, I., de Sousa, V. P., Rodrigues, C. R., da Rocha, E. L. L. M. T.,. Cabral, L. M. (2020). Vancomycin-loaded nanoparticles against vancomycin intermediate and methicillin resistant Staphylococcus aureus strains. Nanotechnology, 31(37), 375101.
  14. EUCAST Web site. (2021). European Committee on Antimicrobial Susceptibility Testing. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_11.0_Breakpoint_Tables.pdf Accessed date: 9.12.2021.
  15. Tewes, F., Munnier, E., Antoon, B., Ngaboni Okassa, L., Cohen-Jonathan, S., Marchais, H.,. Chourpa, I. (2007). Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm, 66(3), 488-492.
  16. Sabaeifard, P., Abdi-Ali, A., Soudi, M. R., Gamazo, C., & Irache, J. M. (2016). Amikacin loaded PLGA nanoparticles against Pseudomonas aeruginosa. Eur J Pharm Sci, 93, 392-398.
  17. Seju, U., Kumar, A., & Sawant, K. K. (2011). Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: In vitro and in vivo studies. Acta Biomaterialia, 7(12), 4169-4176.
  18. Quintanar-Guerrero, D., Fessi, H., Allémann, E., & Doelker, E. (1996). Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique. International Journal of Pharmaceutics, 143(2), 133-141.
  19. Mainardes, R. M., & Evangelista, R. C. (2005). PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. International Journal of Pharmaceutics, 290(1), 137-144.
  20. Bacanlı, M., Eşi̇m, Ö., Erdoğan, H., Sarper, M., Erdem, O., & Özkan, Y. (2021). Evaluation of cytotoxic and genotoxic effects of paclitaxel-loaded PLGA nanoparticles in neuroblastoma cells. Food and Chemical Toxicology, 154, 112323.
  21. Tefas, L. R., Tomuţă, I., Achim, M., & Vlase, L. (2015). Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design. Clujul medical (1957), 88(2), 214-223.
  22. Elsewedy, H. S., Dhubiab, B. E. A., Mahdy, M. A., & Elnahas, H. M. (2020). Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles. Drug Delivery, 27(1), 1134-1146.
  23. Murakami, H., Kobayashi, M., Takeuchi, H., & Kawashima, Y. (1999). Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm, 187(2), 143-152.
  24. Singh, G., Tanurajvir, K., Ravinder, K., & Kaur, A. (2014). Recent biomedical applications and patents on biodegradable polymer-PLGA. International Journal of Pharmacology and Pharmaceutical Sciences, 1, 30-42.
  25. Sunanda Laxmi, P., Vidyavathi, M., & Venkata, S. K. R. (2021). DoE approach for development of localized controlled release microspheres of Vancomycin for treatment of septic arthritis. Future Journal of Pharmaceutical Sciences, 7(1).
  26. Alonso, M. J., Losa, C., Calvo, P., & Vila-Jato, J. (1991). Approaches to improve the association of amikacin sulphate to poly(alkylcyanoacrylate) nanoparticles. International Journal of Pharmaceutics, 68(1), 69-76.
  27. Abeylath, S. C., Turos, E., Dickey, S., & Lim, D. V. (2008). Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis. Bioorg Med Chem, 16(5), 2412-2418.
  28. Simon, A., Moreira, M. L. A., Costa, I., de Sousa, V. P., Rodrigues, C. R., da Rocha, E. L. L. M. T.,. Cabral, L. M. (2020). Vancomycin-loaded nanoparticles against vancomycin intermediate and methicillin resistant Staphylococcus aureus strains. Nanotechnology, 31(37), 375101.
  29. Tewes, F., Munnier, E., Antoon, B., Ngaboni Okassa, L., Cohen-Jonathan, S., Marchais, H.,. Chourpa, I. (2007). Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm, 66(3), 488-492.